Skip to content
About Us
Menu Toggle
Overview
Founder
Executives
Scientific Advisors
Board of Directors, T-E Pharma Holding
Technologies
Menu Toggle
Overview
T-E
TM
Pharmaceuticals
Multi-arm linkers
Packed multi-arm linkers
Fatty acid bundles
Cytotoxic drug bundles
Chelator bundles
Antibody drug conjugates (ADCs)
Antibody radionuclide conjugates (ARCs)
Bispecific Antibodies
Products
Menu Toggle
Overview
TE-8105
TE-8214
TE-8035
TE-6168
TE-1146
TE-1132
CHO-TEM ADCs
News and Honours
Menu Toggle
Join our presentation at the World ADC San Diego 2023!
T-E Meds has received an invitation to present the latest ADC technology platform at the World ADC San Diago conference
T-E Meds and CHO Pharma offer complementary technologies to form a robust ADC development platform
Our latest research result is published in J. Med. Chem.
Immunwork links future to T-E Meds, promoting ADC, ARC platforms development
BIO 2023 International Convention in Boston
Language
Menu Toggle
English
繁體中文
About Us
Menu Toggle
Overview
Founder
Executives
Scientific Advisors
Board of Directors, T-E Pharma Holding
Technologies
Menu Toggle
Overview
T-E
TM
Pharmaceuticals
Multi-arm linkers
Packed multi-arm linkers
Fatty acid bundles
Cytotoxic drug bundles
Chelator bundles
Antibody drug conjugates (ADCs)
Antibody radionuclide conjugates (ARCs)
Bispecific Antibodies
Products
Menu Toggle
Overview
TE-8105
TE-8214
TE-8035
TE-6168
TE-1146
TE-1132
CHO-TEM ADCs
News and Honours
Menu Toggle
Join our presentation at the World ADC San Diego 2023!
T-E Meds has received an invitation to present the latest ADC technology platform at the World ADC San Diago conference
T-E Meds and CHO Pharma offer complementary technologies to form a robust ADC development platform
Our latest research result is published in J. Med. Chem.
Immunwork links future to T-E Meds, promoting ADC, ARC platforms development
BIO 2023 International Convention in Boston
Language
Menu Toggle
English
繁體中文
Other T-E Drugs
Technology: Multi-arm linkers
Product: TE-6168
Scroll to Top
